Therapeutic targets of triple-negative breast cancer: a review-Reference-Cited by-同舟云学术

Therapeutic targets of triple-negative breast cancer: a review

Published:2015-07-30 Issue:17 Volume:172 Page:4228-4237
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Jamdade Vinayak S¹,Sethi Nikunj²³,Mundhe Nitin A¹,Kumar Parveen¹,Lahkar Mangala¹⁴,Sinha Neeraj²³

Affiliation:

1. Laboratory of Molecular Pharmacology and Toxicology; Department of Pharmacology and Toxicology; National Institute of Pharmaceutical Education and Research (NIPER); Gauhati Medical College; Guwahati India

2. Academy of Scientific and Innovative Research (AcSIR); New Delhi India

3. Division of Toxicology; CSIR-Central Drug Research Institute; Lucknow India

4. Laboratory of Pharmacology; Department of Pharmacology; Gauhati Medical College; Guwahati India

Funder

National Institute of Pharmaceutical Education and Research (NIPER), Guwahati

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13211/fullpdf

Reference72 articles.

1. Notch signaling pathway as a therapeutic target in breast cancer;Al-Hussaini;Mol Cancer Ther,2011

2. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors;Alexander;Br J Pharmacol,2013a

3. The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors;Alexander;Br J Pharmacol,2013b

4. The Concise Guide to PHARMACOLOGY 2013/14: enzymes;Alexander;Br J Pharmacol,2013c

5. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization;Assoian;J Biol Chem,1983

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AG8 Reduces Hypoxia-induced Triple Negative Breast Cancer Metastasis by Stemness Regulation;Clinical Complementary Medicine and Pharmacology;2024-03

2. Cancer cell‐derived exosomal miR‐20a‐5p inhibits CD8⁺ T‐cell function and confers anti‐programmed cell death 1 therapy resistance in triple‐negative breast cancer;Cancer Science;2023-12-21

3. Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland;PharmacoEconomics - Open;2023-11-24

4. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype;Biomedicines;2023-11-09

5. Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1;eLife;2023-10-03